ArthroCare says it’s agreed to extend its deal with the U.S. Justice Dept. for another month in a probe of its spinal business.
ArthroCare (NSDQ:ARTC) and the U.S. Justice Dept. extended by a month the statute of limitations on a federal inquiry from the U.S. Dept. of Justice in to the company’s spinal business.
In January Austin, Texas-based ArthroCare said it was pushing the deal out until March 1. That extension was added to Feb. 27, pushing the deal out to March 30, according to a regulatory filing.
“At this stage of the ongoing investigation by the DOJ, the Company cannot predict its ultimate outcome and is unable to estimate any potential liability the Company may incur,” according to the filing.